Clinical efficacy of valsartan combined with folic acid in treatment of elderly hypertensive nephropathy
- VernacularTitle:缬沙坦联合叶酸治疗老年高血压肾病的疗效研究
- Author:
Zhiling LI
;
Xinwei XU
;
Ping CAI
;
Hongyan LI
;
Shaogang SUN
;
Liangyong WU
- Publication Type:Journal Article
- Keywords:
vallarta;
folic acid;
essential hypertension;
hypertensive nephropathy;
elderly
- From:
Chinese Journal of Biochemical Pharmaceutics
2014;37(4):123-125
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical efficacy of vallarta combined with folic acid in treatment of elderly hypertensive nephropathy.Methods 120 patients of essential hypertension with renal failure in Weifang People’s Hospital were divided into control group and observation group according to the odd and even numbers.The observation group was given vallarta and folic acid,the control group were given vallarta.4 weeks later,the effect of two groups were evaluated.Systolic and diastolic blood pressure,serum cretonne,blood urea nitrogen and 24h urinary protein were measured before and after treatment. Results The patients after treatment systolic and diastolic pressure was significantly better than control group, the difference was statistically significant(P<0.05),serum creatinine,blood urea nitrogen and 24h urine protein test results were better than control group,the difference was statistically significance(P<0.05).The total effective rate of observation group was better than control group(P<0.05),the obvious effective rate of observation group was significantly better than control group(P<0.01).Conclusion Combination of valsartan and folic acid in treatment of elderly hypertensive nephropathy has a higher total effective rate,while significantly lower blood pressure,serum creatinine,blood urea nitrogen and 24h urinary protein.
